Large shareholder group calls for a board overhaul at pharma company CytoDyn
July 24, 2021 at 08:06 AM EDT
Paul Rosenbaum, CEO of SWR Corp., is no stranger to shareholder activism. He’s leading a group of investors calling for change at CytoDyn.
